Clinical application of multi-contrast 7-T MR imaging in multiple sclerosis: increased lesion detection compared to 3 T confined to grey matter.
about
Ultrahigh field MRI in clinical neuroimmunology: a potential contribution to improved diagnostics and personalised disease managementGrey matter damage in multiple sclerosis: a pathology perspectiveCurrent and new directions in MRI in multiple sclerosisMRI at 7 Tesla and above: demonstrated and potential capabilities.Clinical proton MR spectroscopy in central nervous system disordersMRI in the Diagnosis and Monitoring of Multiple Sclerosis: An Update.Rapid parametric mapping of the longitudinal relaxation time T1 using two-dimensional variable flip angle magnetic resonance imaging at 1.5 Tesla, 3 Tesla, and 7 TeslaTissue transglutaminase in marmoset experimental multiple sclerosis: discrepancy between white and grey matter.Clinical applications at ultrahigh field (7 T). Where does it make the difference?The Parallel Analysis of Phase Sensitive Inversion Recovery (PSIR) and Double Inversion Recovery (DIR) Images Significantly Improves the Detection of Cortical Lesions in Multiple Sclerosis (MS) since Clinical Onset.Regional Distribution and Evolution of Gray Matter Damage in Different Populations of Multiple Sclerosis PatientsThe technological future of 7 T MRI hardware.Increased cortical grey matter lesion detection in multiple sclerosis with 7 T MRI: a post-mortem verification study.In-vivo imaging of meningeal inflammation in multiple sclerosis: Presence of evidence or evidence of presence?Comparison of Routine Brain Imaging at 3 T and 7 T.Causes, effects and connectivity changes in MS-related cognitive decline.Approaching ultimate intrinsic specific absorption rate in radiofrequency shimming using high-permittivity materials at 7 Tesla.7T MRI Visualization of Cortical Lesions in Adolescents and Young Adults with Pediatric-Onset Multiple Sclerosis.Impact of 3 Tesla MRI on interobserver agreement in clinically isolated syndrome: A MAGNIMS multicentre study.Seven-Tesla Magnetization Transfer Imaging to Detect Multiple Sclerosis White Matter Lesions.Key clinical benefits of neuroimaging at 7T.Improved differentiation between MS and vascular brain lesions using FLAIR* at 7 Tesla.Ultra-High-Field MRI Visualization of Cortical Multiple Sclerosis Lesions with T2 and T2*: A Postmortem MRI and Histopathology Study.Current developments in MRI for assessing rodent models of multiple sclerosis
P2860
Q26796643-74841DBA-7B61-4FFA-88F4-43111702D37FQ30586246-E4A3FFCC-7384-4614-87FE-56D288D89CB6Q30659431-718A872A-EB89-47A7-8A02-3E088AC209D1Q30745387-C8DCCD92-6328-4E5E-92F1-E545A5C73439Q30764446-4B4A36DE-AA84-431A-95C7-6BE1DA2ED1BFQ30981999-9BF0F50A-0182-43C3-982B-6E0EDFFEC7BDQ35118650-37DB7379-3D0B-4BA4-A59A-D37FA69E3A86Q35193921-7D8DE3EB-9B60-4383-ABEE-226CD5460231Q35575469-E1B22B17-F15B-4688-A03F-AF3FB522E234Q35641249-0CBEBC88-E3AF-4E02-811F-B45782D13F1BQ35744057-61885D33-8F36-4BD3-B4FC-09FAF449CE3EQ38480096-89A7940B-AA72-4ED4-91EB-4BE315AFBE2DQ39937897-B2B6A3AF-E460-4FED-BEFA-0100B3CC9D43Q41097983-CB3D119B-DCC0-4BE2-9EBE-7211129E0A88Q47146663-1B13C7C2-BFCC-47E8-9EFE-406314496DEEQ47147953-2E94305D-8CBD-4D1F-9969-035D26225ED5Q47296044-1B5ADDD4-E227-4F26-A431-EE1B502AD1C1Q47670723-1B6D4D1D-A672-4A7E-89BE-B2434CAF89D2Q47868081-BE8E1DA2-8824-41CE-A392-34879982F16BQ47931219-1118CEF1-B3C4-4C4A-B0E7-CC2E006DAE36Q48428333-9CA710CD-1241-4873-86AC-B45C975BD06EQ48819704-863FC357-71EC-429B-9AB3-3CE5C0F2F3EAQ53399890-6D01A654-E5A3-4C29-A8CA-90FCC4D388E0Q57521580-4E183BDD-4C33-4F7E-BC20-E4102E79C0F1
P2860
Clinical application of multi-contrast 7-T MR imaging in multiple sclerosis: increased lesion detection compared to 3 T confined to grey matter.
description
2012 nî lūn-bûn
@nan
2012 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Clinical application of multi- ...... o 3 T confined to grey matter.
@ast
Clinical application of multi- ...... o 3 T confined to grey matter.
@en
type
label
Clinical application of multi- ...... o 3 T confined to grey matter.
@ast
Clinical application of multi- ...... o 3 T confined to grey matter.
@en
prefLabel
Clinical application of multi- ...... o 3 T confined to grey matter.
@ast
Clinical application of multi- ...... o 3 T confined to grey matter.
@en
P2093
P2860
P1433
P1476
Clinical application of multi- ...... o 3 T confined to grey matter.
@en
P2093
Alexandra Lopez-Soriano
Chris H Polman
Fredy Visser
Iris D Kilsdonk
Jaco J M Zwanenburg
Jeroen J G Geurts
Jonas A Castelijns
Mike P Wattjes
Peter R Luijten
Petra J W Pouwels
P2860
P2888
P304
P356
10.1007/S00330-012-2619-7
P407
P577
2012-08-17T00:00:00Z